These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26463167)
21. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague. Olson RM; Dhariwala MO; Mitchell WJ; Anderson DM Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642901 [No Abstract] [Full Text] [Related]
22. Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model. Olson RM; Anderson DM PLoS One; 2019; 14(5):e0217440. PubMed ID: 31121001 [TBL] [Abstract][Full Text] [Related]
23. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection. Dhariwala MO; Olson RM; Anderson DM Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850 [No Abstract] [Full Text] [Related]
24. Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague. Peters KN; Dhariwala MO; Hughes Hanks JM; Brown CR; Anderson DM PLoS Pathog; 2013; 9(4):e1003324. PubMed ID: 23633954 [TBL] [Abstract][Full Text] [Related]
25. Inactivation of Peroxiredoxin 6 by the Pla Protease of Yersinia pestis. Zimbler DL; Eddy JL; Schroeder JA; Lathem WW Infect Immun; 2016 Jan; 84(1):365-74. PubMed ID: 26553463 [TBL] [Abstract][Full Text] [Related]
26. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
28. A Dual Role for the Plasminogen Activator Protease During the Preinflammatory Phase of Primary Pneumonic Plague. Banerjee SK; Crane SD; Pechous RD J Infect Dis; 2020 Jul; 222(3):407-416. PubMed ID: 32128567 [TBL] [Abstract][Full Text] [Related]
29. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Lathem WW; Crosby SD; Miller VL; Goldman WE Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17786-91. PubMed ID: 16306265 [TBL] [Abstract][Full Text] [Related]
30. Monitoring of Neutrophil Recruitment to Mice Lungs During Pneumonic Plague. Vagima Y; Levy Y; Mamroud E Methods Mol Biol; 2019; 2010():141-150. PubMed ID: 31177436 [TBL] [Abstract][Full Text] [Related]
31. Neutrophils are important in early control of lung infection by Yersinia pestis. Laws TR; Davey MS; Titball RW; Lukaszewski R Microbes Infect; 2010 Apr; 12(4):331-5. PubMed ID: 20114086 [TBL] [Abstract][Full Text] [Related]
32. Intranasal Inoculation of Mice with Yersinia pestis and Processing of Pulmonary Tissue for Analysis. Pechous RD Methods Mol Biol; 2019; 2010():17-28. PubMed ID: 31177428 [TBL] [Abstract][Full Text] [Related]
33. Distinct CCR2(+) Gr1(+) cells control growth of the Yersinia pestis ΔyopM mutant in liver and spleen during systemic plague. Ye Z; Uittenbogaard AM; Cohen DA; Kaplan AM; Ambati J; Straley SC Infect Immun; 2011 Feb; 79(2):674-87. PubMed ID: 21149593 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive study on the role of the Yersinia pestis virulence markers in an animal model of pneumonic plague. Kaman WE; Hawkey S; van der Kleij D; Broekhuijsen MP; Silman NJ; Bikker FJ Folia Microbiol (Praha); 2011 Mar; 56(2):95-102. PubMed ID: 21468758 [TBL] [Abstract][Full Text] [Related]
35. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague. Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764 [TBL] [Abstract][Full Text] [Related]
36. Toward a molecular pathogenic pathway for Yersinia pestis YopM. Uittenbogaard AM; Chelvarajan RL; Myers-Morales T; Gorman AA; Brickey WJ; Ye Z; Kaplan AM; Cohen DA; Ting JP; Straley SC Front Cell Infect Microbiol; 2012; 2():155. PubMed ID: 23248776 [TBL] [Abstract][Full Text] [Related]
37. Early sensing of Yersinia pestis airway infection by bone marrow cells. Vagima Y; Levy Y; Gur D; Tidhar A; Aftalion M; Abramovich H; Zahavy E; Zauberman A; Flashner Y; Shafferman A; Mamroud E Front Cell Infect Microbiol; 2012; 2():143. PubMed ID: 23189271 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Parham TE; Baze WB; Suarez G; Peterson JW; Chopra AK Microbiology (Reading); 2008 Jul; 154(Pt 7):1939-1948. PubMed ID: 18599822 [TBL] [Abstract][Full Text] [Related]
39. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Kerschen EJ; Cohen DA; Kaplan AM; Straley SC Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919 [TBL] [Abstract][Full Text] [Related]
40. Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague. Olson RM; Dhariwala MO; Mitchell WJ; Skyberg JA; Anderson DM Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]